儿童屈光参差性弱视患者的Verisyse人工晶状体植入：四年随访
Verisyse intraocular lens implantation in a child with anisometropic amblyopia: four-year follow-up.
作者信息
Assil Kerry K, Sturm Julie M, Chang Steve H
机构信息
Assil Eye Institute, Beverly Hills, California 90210, USA.
出版信息
J Cataract Refract Surg. 2007 Nov;33(11):1985-6. doi: 10.1016/j.jcrs.2007.06.038.
A Verisyse phakic intraocular lens (pIOL) (AMO) was implanted in the eye of a 3-year-old child with unilateral high myopia and suspected dense amblyopia. Four years postoperatively, the Snellen visual acuity was 20/30 with a refraction of -1.00 -1.00 x 77 and the endothelial cell density was 3262 cells/mm(2) compared with 3092 cells/mm(2) in the right eye. The Verisyse pIOL may be a treatment option to prevent dense amblyopia in children with highly myopic anisometropia.
一枚Verisyse有晶状体眼人工晶状体（pIOL）（AMO公司）被植入一名3岁单侧高度近视且疑似重度弱视儿童的眼中。术后4年，斯内伦视力为20/30，屈光度为-1.00 -1.00×77，内皮细胞密度为3262个细胞/mm²，而右眼为3092个细胞/mm²。Verisyse pIOL可能是预防高度近视性屈光参差儿童发生重度弱视的一种治疗选择。
Zotero 插件